
Pfizer (NYSE:PFE) shares are trading higher Wednesday after President Donald Trump announced a drug-pricing deal with the company.
What To Know: Trump said Pfizer will voluntarily cut prices on many of its drugs for Medicaid patients, with discounts averaging 50% and reaching as high as 85%. The deal covers a wide range of the company's primary care and specialty brand-name medicines.